Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Union Jack Oil Secures £2 Million to Drive U.S. Expansion – Lighthouse Equity Research 12 August 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Union Jack Oil Secures £2 Million to Drive U.S. Expansion – Lighthouse Equity Research 12 August 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
Natera, Inc. (NTRA) Stock Analysis: A Look at the Diagnostics Leader’s Growth Potential and Analyst Confidence 22 September 2025
Sanofi (SNY) Investor Outlook: Exploring a 29% Upside Potential Amidst Strong Dividend Yields 22 September 2025
Vertex Pharmaceuticals (VRTX): Investor Outlook Highlights 25% Potential Upside Amidst Strong Revenue Growth 22 September 2025
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 25.98% Potential Upside 22 September 2025
Zimmer Biomet Holdings (ZBH) Investor Outlook: Unlocking a Potential 11.7% Upside in the Medical Device Sector 22 September 2025
Summit Therapeutics Inc. (SMMT) Stock Analysis: Assessing a 73% Potential Upside Amidst Clinical Innovations 22 September 2025
Amgen Inc. (AMGN) Stock Analysis: Solid Dividend Yield and Strong ROE Highlight Investment Appeal 22 September 2025
Elevance Health, Inc. (ELV) Stock Analysis: Navigating a 18.08% Potential Upside in the Healthcare Sector 22 September 2025
UnitedHealth Group (UNH) Stock Analysis: Consistent Growth in Healthcare with a 2.63% Dividend Yield for Investors 22 September 2025
BeOne Medicines Ltd. (ONC) Investor Outlook: Strong Buy Ratings Signal Promising Upside Potential 22 September 2025
Zoetis Inc. (ZTS) Stock Analysis: A Compelling 30% Upside in the Expanding Animal Health Sector 22 September 2025
Gilead Sciences, Inc. (GILD) Stock Analysis: Key Metrics and Growth Potential for Investors 22 September 2025
Pfizer, Inc. (PFE) Stock Analysis: Exploring a 20% Potential Upside with Strategic Investments 22 September 2025
Medtronic plc (MDT) Stock Analysis: Navigating Healthcare Growth with a 3.73% Upside 22 September 2025
McKesson Corporation (MCK) Stock Analysis: Exploring a 12.93% Upside in the Healthcare Giant 22 September 2025
Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 21% Potential Upside 22 September 2025
Abbott Laboratories (ABT) Stock Analysis: A Healthcare Leader with 4.91% Potential Upside 22 September 2025
Johnson & Johnson (JNJ) Investor Outlook: Analyzing a $424 Billion Healthcare Giant’s Growth and Dividend Potential 22 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video) 10 September 2025
Likewise Group: Scaling Fast with Sales Growth, Dividends and Distribution Muscle (Video) 10 September 2025
Cerillion Plc Gartner Magic Quadrant Recognition and the AI Edge Telcos Cannot Ignore 9 September 2025
Intertek acquires Professional Testing Laboratory to expand flooring testing services 26 November 2025
Compass Group Reports Strong Full-Year Results with Double-Digit Profit Growth and Strategic European Acquisition 25 November 2025
Sequoia Economic Infrastructure Income Fund reports strong first half NAV and income growth 28 November 2025
Pennon Group returns to profit with strong H1 performance and operational improvements 27 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Union Jack Oil Secures £2 Million to Drive U.S. Expansion – Lighthouse Equity Research 12 August 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
